Preview

Bulletin of Siberian Medicine

Advanced search

The influence of smoking on the formation of airway hyperresponsiveness to cold and the course of destructive-cytological processes in the goblet cells of the bronchial epithelium in patients with asthma

https://doi.org/10.20538/1682-0363-2019-3-90-100

Abstract

Tobacco smoking in patients with asthma can intensify the bronchi mucosa damage and significantly worsen the course of the disease.

Aim. To assess the influence of tobacco smoking on the clinical manifestations of the disease, airway response to cold air exposure and destructive-cytological processes in the goblet cells of bronchial epithelium in patients with asthma.

Materials and methods. In 145 patients with asthma their asthma control level was determined by the Аsthma Control Test, lung function (FEV1 , %) and airway response (∆FEV1 , %) to a 3-minute isocapnic hyperventilation (–20 °С) of cold air (IHCA) were evaluated, and induced sputum (IS) was collected. In cytograms of IS a percentage content, the index of cell destruction (ICD) and the index of cytolysis intensiveness (IC) were assessed; histochemically the activity of myeloperoxidase (MPO) and the contents of glycoproteins were identified. The 1st group included 102 non-smokers and the 2nd group included 43 smokers.

Results. In IS of patients of the 2nd group in comparison with the 1st one we found intensification of the destructive (ICD = 0.47 ± 0.02 and 0.40 ± 0.02, respectively, р = 0.044) and cytolytic activity of goblet cells (IC = 0.22 ± 0.03 and 0.15 ± 0.02, respectively, р = 0.047) with the domination of the number of completely destroyed cells (21.7 ± 2.4 vs. 14.5 ± 1.6%, р = 0.043) and the decrease in the number of cells with a normal structure (52.5 ± 2.1 vs. 60.5 ± 3.1%, р = 0.047). For smokers it was typical to have high contents of neutrophils in IS (34.1 ± 3.0 vs. 23.9 ± 1.4%, respectively, р = 0.0006) and high level of myeloperoxidase in granulocytes of bronchi (94.3 ± 5.4 vs. 80.7 ± 3.6 pixels, р = 0.037). Smokers responded more actively to IHCA (∆FEV1 was –13.7 ± 2.6 vs. –7.9 ± 1.2%, respectively, р = 0.032), and the degree of the response correlated with the indices of destructive-cytological activity of IS cells.

Conclusion. Tobacco smoking in patients with asthma leads to the disturbance of the structure of goblet epithelium in the bronchi with the intensification of destructive-cytological processes, which is accompanied by a decrease in the level of glycoproteins in cytoplasm, an increase in the secretory activity of the goblet cells, neutrophilia, growth of oxidative peroxidase activity of granulocytes, worsening of the bronchial conductance, and intensification of airway response to cold air. 

About the Authors

A. B. Pirogov
Far Eastern Scientific Center of Respiratory Physiology and Pathology
Russian Federation

PhD, Associate Professor, Senior Scientist, Laboratory of Prophylaxis of Nonspecific Lung Diseases, 

22, Kalinina Str., Blagoveschensk, 675000



A. G. Prikhodko
Far Eastern Scientific Center of Respiratory Physiology and Pathology
Russian Federation

DM, Chief Scientist, Laboratory of Functional Research of Respiratory System,

22, Kalinina Str., Blagoveschensk, 675000



V. P. Kolosov
Far Eastern Scientific Center of Respiratory Physiology and Pathology
Russian Federation

DM, Professor, Director,

22, Kalinina Str., Blagoveschensk, 675000



Ju. M. Perelman
Far Eastern Scientific Center of Respiratory Physiology and Pathology
Russian Federation

DM, Professor, Head of the Laboratory of Functional Research of Respiratory System,

22, Kalinina Str., Blagoveschensk, 675000



References

1. Gambaryan M.G. Chronic respiratory diseases and tobacco use (review). Medical Council. 2016; 17: 144–152 (in Russ.). DОI: 10.21518/2079-701X2016-17-144-152.

2. Krasnova Yu.N. Effect of tobacco smoke on the respiratory system. Siberian Medical Journal. 2015; 137 (6): 11–16 (in Russ.).

3. Backman H., Hedman L., Jansson S., Lindberg А., Lundbück В., Rönmark Е. Prevalence trends in respiratory symptoms and asthma in relation to smoking – two cross-sectional studies ten years apart among adults in northern Sweden. World Allergy Organ. J. 2014; 7 (1): 1–7. DОI: 10.1186/1939-4551-7-1.

4. Polosa R., Russo C., Caponnetto P., Bertino G., Sarvа М., Antic Т., Mancuso S., Al-Delaimy W. Greater severity of new onset asthma in allergic subjects who smoke: a 10- year longitudinal study. Respiratory Research. 2011; 12 (1): 16. DОI: 10.1186/1465-9921-12-16.

5. Chalmers G.W., Macleod K.J., Little S.A., Thomson L.J., McSharry C.P., Thomson N.C. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax. 2002; 57 (3): 226–230. DОI: 10.1136/thorax.57.3.226.

6. Thomson N.C., Spears M. The influence of smoking on the treatment response in patients with asthma. Curr. Opin. Allergy Clin. Immunol. 2005; 5 (1): 57–63. DОI: 10.1097/00130832-200502000-00011.

7. Boulet L.P., FitzGerald J.M., McIvor R.A., Zimmerman S., Chapman K.R. Influence of current or former smoking on asthma management and control. Can. Respir. J. 2008; 15 (5): 275–279. DОI: 10.1155/2008/725074.

8. Perelman N.L. Effects of tobacco smoking on health-related quality of life in patients with asthma. Bulletin Physiology and Pathology of Respiration. 2014; 53: 30–35 (in Russ.).

9. Juusela M., Pallasaho P., Rönmark E., Sarna S., Sovijürvi A., Lundbück B. Dose-dependent association of smoking and bronchial hyperresponsiveness. Eur. Respir. J. 2013; 42: 1503–1512. DОI: 10.1183/09031936.00073712.

10. Pirogov A.B., Perelman J.M., Prikhodko A.G., Zinov’ev S.V. Influence of the neutrophilic component of bronchial inflammation on the level of disease control and lung function in patients with asthma. Bulletin Physiology and Pathology of Respiration. 2016; 61: 16–24 (in Russ.). DOI: 10.12737/21434.

11. Pirogov A.B., Kolosov V.P., Perelman J.M., Prikhod’ko A.G., Zinov’ev S.V., Gassan D.A., Mal’tseva T.A. Airway inflammation patterns and clinical and functional features in patients with severe uncontrolled asthma and cold-induced airway hyperresponsiveness. Russian Pulmonology. 2016; 26 (6): 701–707 (in Russ.). DОI: 0.18093/086901892016266701707.

12. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention (Updated 2016). URL: http://www.ginasthma.com.

13. Prikhodko A.G., Perelman J.M., Kolosov V.P. Airway hyperresponsiveness. Vladivostok: Dal’nauka Publ., 2011: 204 (in Russ.).

14. Bakakos P., Schleich F., Alchanatis M., Louis R. Induced sputum in asthma: From bench to bedside. Curr. Med. Chem. 2011; 18 (10): 1415–1422. DOI: 10.2174/092986711795328337.

15. Matveeva L.А. Local protection of the respiratory tract in children. Tomsk: Tomsk University Publ., 1993: 276 (in Russ.).

16. Hauhoe F.G.J., Quaglino D. Hematologic cytochemistry. рer. s angl; рod red. N.S. Kislyak. Moscow: Meditsina Publ., 1983 (in Russ.).

17. Medical laboratory technologies: a guide on clinical laboratory diagnostics in 2 vol.; pod red. А.I. Karpishhenko; 3-e izd., pererab. i dop. Moscow: GEHOTАR-Media Publ., 2012: 472 (in Russ.).

18. Soodaeva S.K., Klimanov I.А. Disorders of oxidative metabolism in respiratory diseases and modern approaches to antioxidant therapy. Atmosphere. Pulmonology and Аllergology. 2009; (1): 34–38 (in Russ.).

19. Soodaeva S.K. Free radical mechanisms of injury in respiratory disease. Russian Pulmonology. 2012; 1: 5–10 (in Russ.). DOI: 10.18093/0869-0189-2012-0-1-5-10.

20. Jin Y.S., Park K.K., Park J.Y., Kim M.J., Lee W.L., im H.Y., Lee H. J., Park E.K. Effects of exercise induced oxidative stress and antioxidant supplementation on NF-kB activation in peripheral mononuclear cells. Korean J. Sports Med. 2000; 18 (2): 261–270.

21. Vasil’eva G.I., Ivanova I.А., Tyukavkina S.Yu. Cooperative interaction of mono- and polynucleated phagocytes, mediated by mono- and neutrophilokines. Immunology. 2000; (5): 11–17 (in Russ.)].

22. Kuwano K. Epithelial cell apoptosis and lung remodeling. Cell. Mol. Immunol. 2007; 4 (6): 419–429.

23. Konishcheva A.Y., Gervazieva V.B., Lavrentyeva E.E. Changes in the structure and function of respiratory epithelium in bronchial asthma. Russian Pulmonology. 2012; 5: 85–91 (in Russ.). DOI: 10.18093/0869-0189-2012-0-5-85-91.

24. Panasenko O.M., Sergienko V.I. Halogenated stress and its biomarkers. Herald of RAMS. 2010; 1: 27–39 (in Russ.).

25. Wood L.G., Baines K.I., Fu J. Scott H.A., Gibson P.G. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest. 2012; 142 (1): 86–93. DOI: 10.1378/chest.11-1838.

26. Pirogov A.B., Zinov’ev S.V., Perelman J.M., Prikhodko A.G., Kolosov V.P. Destructive-cytolytic activity of bronchial epithelium and its influence on the development of cold airway hyperresponsiveness in patients with asthma. Respirology. 2017; 22 (3): 172.

27. Нolgate S.T. Epithelium dysfunction in asthma. J. Allergy Clin. Immunol. 2007; 120 (6): 1233–1244. DOI: 10.1016/j.jaci.2007.10.025.


Review

For citations:


Pirogov A.B., Prikhodko A.G., Kolosov V.P., Perelman J.M. The influence of smoking on the formation of airway hyperresponsiveness to cold and the course of destructive-cytological processes in the goblet cells of the bronchial epithelium in patients with asthma. Bulletin of Siberian Medicine. 2019;18(3):90-100. (In Russ.) https://doi.org/10.20538/1682-0363-2019-3-90-100

Views: 1134

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-0363 (Print)
ISSN 1819-3684 (Online)